USFDA issues 15 observations for Jubilant HollisterStier General Partnership Montreal facility Ruchika Sharma19 Jun 2024 5:45 AMNoida: Jubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has concluded the audit of the...
USFDA concludes audit at Jubilant Generics Roorkee site Ruchika Sharma3 Feb 2024 8:00 AMNoida: Jubilant Pharmova Limited announced that the United States Food and Drug Administration (USFDA) has concluded audit of the solid dosage...
Jubilant Generics Roorkee facility determined as official action indicated Ruchika Sharma31 Oct 2022 7:16 AMNoida: Jubilant Pharmova Limited's wholly owned subsidiary Jubilant Pharma Limited, today announced that its subsidiary Jubilant Generics Limited...
Jubilant Pharmova Roorkee facility gets 6 USFDA observations Rahul Verma5 Aug 2022 10:42 AMJubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has recently concluded audit of the Solid Dosage...
USFDA issues 6 observations for Jubilant Pharmova Roorkee facility Ruchika Sharma3 Aug 2022 6:45 AMNoida: Jubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has recently concluded audit of the Solid...
USFDA removes Jubilant Generics' Olanzapine, Spironolactone and Valsartan from list of excepted products from import Ruchika Sharma14 July 2022 10:39 AMPost this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.
Jubilant to double US injectable capacity at cost of Rs 1498 crore Ruchika Sharma31 May 2022 6:16 AMThis agreement is in addition to the $92 million filling line expansion announced in November 2021, which will be commercially available by the end of...
Jubilant Pharma announces the development of a novel oral formulation of Remdesivir in animals MD Bureau19 March 2022 8:52 AMThis innovative formulation is likely to ease the capacity constraint that injectable formulation faces and ensure wider and timely availability for...
Jubilant Pharma to remain integral to group post reorganisation: SnP Ruchika Sharma18 Aug 2021 7:31 AMSingapore: S&P Global Ratings said on Tuesday that Jubilant Pharma Ltd will remain integral to the broader group even after its proposed...
Despite import alert for India plant, Jubilant Pharma rating headroom healthy: Fitch Ruchika Sharma27 July 2021 9:52 AMSingapore: Jubilant Pharma Ltd (JPL) will continue to maintain good rating headroom as the impact of a recent US Food and Drug Administration import...
Cipla, Jubilant get show-cause notice for failing to supply committed quantities of Remdesivir to Karnataka Ruchika Sharma13 May 2021 9:23 AMBengaluru: Given the sudden spike in the demand for Remdesivir antiviral injections amid the raging second wave of the Covid-19 pandemic, Karnataka on...
Jubilant Pharma wins patent suits filed by Bracco Diagnostics in US court Ruchika Sharma11 May 2021 4:30 AMNoida: Jubilant Pharma Limited, a subsidiary of Jubilant Pharmova Limited, has recently announced that it has received a favorable and unanimous...
